Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-PHENO-24136

Xla Wt + spinal cord amputation, Edwards-Faret G et al. (2021)

Experiment + Assay: Xla Wt + spinal cord amputation + NF50 + 2 dpt ( immunohistochemistry)
Background: Xla.pigmentedNasco
Manipulations:
Manipulation Type Reagent Target Gene Stage Treatment Area
amputation/regeneration  
NF stage 50 spinal cord
Conditions:
Assay Type Assay Stages Antibody
immunohistochemistry NF stage 50  
Expression Phenotypes (11):
increased amount aldh1l1.L expression in spinal cord
increased amount ascl1.L expression in spinal cord
increased amount dcx.L expression in spinal cord
increased amount mbp.L expression in spinal cord
increased amount nes.L expression in spinal cord
increased amount neurod1.L expression in spinal cord
increased amount neurog2.L expression in spinal cord
increased amount neurog3.L expression in spinal cord
increased amount sox10.L expression in spinal cord
increased amount sox2.L expression in spinal cord
increased amount vim.L expression in spinal cord
Source: Fig. 2. C-M
Article: XB-ART-57773, PubMed